Saturday, October 31, 2026

NASDAQ 100 Over 5% Down In The Last 10 Sessions

ViaNews Editorial Team

October 27, 2023

NASDAQ 100 Over 5% Down In The Last 10 Sessions

(VIANEWS) - NASDAQ 100 (NDX) has been up by 5.45% for the last 10 sessions. At 13:08 EST on Friday, 27 October, NASDAQ 100 (NDX) is $14,178.61.

Volume

Today's last reported volume for NASDAQ 100 is 556276035, 78.02% below its average volume of 2530899048.87.

About NASDAQ 100's yearly highs and lows, it's 33.35% up from its 52-week low and 11.01% down from its 52-week high.

Volatility

NASDAQ 100's last week, last month's, and last quarter's current intraday variation average was a negative 0.80%, a negative 0.16%, and a positive 0.91%, respectively.

NASDAQ 100's highest amplitude of average volatility was 1.43% (last week), 1.03% (last month), and 0.91% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NASDAQ 100's is considered to be overbought (>=80).

Previous days news about NASDAQ 100 (NDX)

  • Nasdaq 100 forecast: shows negativity - 26 October 2023. According to DailyForex on Thursday, 26 October, "If that does in fact expand at this point, that could probably send stock markets around the world much lower, and of course, the NASDAQ 100 won't be spared this downward pressure.", "The NASDAQ 100 of course is much more volatile than other indices in the United States, so maybe the first one to get hammered."

News about

  • According to MarketWatch on Wednesday, 25 October, "The stock has fallen 20.4% in the year to date, while the S&P 500 has gained 10.6%."
  • According to MarketWatch on Wednesday, 25 October, "The Dow Jones Industrial Average opened higher on Wednesday as a post-earnings rally in shares of Microsoft Corp. helped lift the blue-chip gauge while the S&P 500 and Nasdaq Composite sunk. ", "Meanwhile, the S&P 500 shed 22 points, or 0.5%, to 4,225, and the Nasdaq fell by 135 points, or 1.1%, to 13,000. "
  • According to FXStreet on Wednesday, 25 October, "Despite the long-term market breadth signals a red flag while the short-term market breadth approaches the deeply oversold level, it is critical to monitor the S&P 500 as discussed in the video to get the confirmation."
  • According to DailyForex on Wednesday, 25 October, "Ultimately, the S&P 500 exhibited early strength in Tuesday's trading session amidst ongoing market volatility. ", "However, it's important to acknowledge that the S&P 500 is currently characterized by a high degree of noise. "

More news about NASDAQ 100 (NDX).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com